Onkologie. 2022:16(1):33-37 | DOI: 10.36290/xon.2022.006

Treatment options for rectal cancer

Filip Pazdírek1, Michal Vjaclovský1, Marek Grega2, Jiří Hoch1
1 Chirurgická klinika 2. LF UK a FN Motol, Praha
2 Ústav patologie a molekulární medicíny 2. LF UK a FN Motol, Praha

Colorectal cancer (CRC) is one of the most common malignancies in all developed countries. Thanks to the introduction of colorectal cancer screening in the Czech Republic, an improvement in the situation has been observed in recent years, especially a stabilization of incidence and a decrease in mortality. Colon and rectal cancer has many similarities, but there are some differences between them, especially in treatment. The current treatment of rectal cancer is multimodal. The refinement of imaging methods, surgical and onco­logical treatment has led to a significant improvement in the prognosis of patients in recent years. The risk of local recurrence has decreased and most patients end up with sphincter-saving surgery. The introduction of minimally invasive surgery has shortened patients' recovery while maintaining oncological radicality. To ensure a good outcome, patients should be treated in cancer centres.

Keywords: tumor, cancer, carcinoma, rectum, treatment, multimodal.

Published: February 22, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pazdírek F, Vjaclovský M, Grega M, Hoch J. Treatment options for rectal cancer. Onkologie. 2022;16(1):33-37. doi: 10.36290/xon.2022.006.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. 2020. G. Cancer Today. 2020, http://gco.iarc.fr.
    2. SVOD. Epidemiologie zhoubných nádorů v České republice. 2018, www.svod.cz.
    3. UZIS. Ústav zdravotnických informací a statistiky ČR. www.uzis.cz.
    4. Petruželka L. Kolorektální karcinom. Praha: Farmakon Press; 2018.
    5. Steele S. The ASCRS textbook of colon and rectal surgery. New York: Springer; 2016. Go to original source...
    6. Fokas E, Liersch T, Fietkau R, Hohenberger W, Beissbarth T, Hess C, et al. Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial. J Clin Oncol. 2014;32(15):1554-1562. Go to original source... Go to PubMed...
    7. Lam AK-Y, Chan SS-Y, Leung M. Synchronous colorectal cancer: clinical, pathological and molecular implications. World journal of gastroenterology. 2014;20(22):6815-6820. Go to original source... Go to PubMed...
    8. Cheng Q, Pang TC, Hollands MJ, Richardson AJ, Pleass H, Johnston ES, et al. Systematic review and meta-analysis of laparoscopic versus open distal gastrectomy. J Gastrointest Surg. 2014;18(6):1087-1099. Go to original source... Go to PubMed...
    9. Suzuki C, Torkzad MR, Tanaka S, Palmer G, Lindholm J, Holm T, et al. The importance of rectal cancer MRI protocols on interpretation accuracy. World journal of surgical oncology. 2008;6:89. Go to original source... Go to PubMed...
    10. Kaur H, Choi H, You YN, Rauch GM, Jensen CT, Hou P, et al. MR imaging for preoperative evaluation of primary rectal cancer: practical considerations. Radiographics. 2012;32(2):389-409. Go to original source... Go to PubMed...
    11. Merkel S, Mansmann U, Papadopoulos T, Wittekind C, Hohenberger W, Hermanek P. The prognostic inhomogeneity of colorectal carcinomas Stage III: a proposal for subdivision of Stage III. Cancer. 2001;92(11):2754-2759. Go to original source...
    12. Maizlin ZV, Brown JA, So G, Brown C, Phang TP, Walker ML, et al. Can CT replace MRI in preoperative assessment of the circumferential resection margin in rectal cancer? Dis Colon Rectum. 2010;53(3):308-314. Go to original source... Go to PubMed...
    13. van de Velde CJ, Boelens PG, Tanis PJ, Espin E, Mroczkowski P, Naredi P, et al. Experts reviews of the multidisciplinary consensus conference colon and rectal cancer 2012: science, opinions and experiences from the experts of surgery. Eur J Surg Oncol. 2014;40(4):454-468. Go to original source... Go to PubMed...
    14. Smith NJ, Barbachano Y, Norman AR, Swift RI, Abulafi AM, Brown G. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg. 2008;95(2):229-236. Go to original source... Go to PubMed...
    15. Dresen RC, Peters EE, Rutten HJ, Nieuwenhuijzen GA, Demeyere TB, van den Brule AJ, et al. Local recurrence in rectal cancer can be predicted by histopathological factors. Eur J Surg Oncol. 2009;35(10):1071-1077. Go to original source... Go to PubMed...
    16. Bipat S, Glas AS, Slors FJ, Zwinderman AH, Bossuyt PM, Stoker J. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging--a meta-analysis. Radiology. 2004;232(3):773-783. Go to original source... Go to PubMed...
    17. Ptok H, Marusch F, Meyer F, Wendling P, Wenisch HJ, Sendt W, et al. Feasibility and accuracy of TRUS in the pre-treatment staging for rectal carcinoma in general practice. Eur J Surg Oncol. 2006;32(4):420-425. Go to original source... Go to PubMed...
    18. Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cervantes A, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Annals of Oncology. 2017;28(suppl_4):iv22-iv40. Go to original source... Go to PubMed...
    19. Kiss I. Modrá kniha České onkologické společnosti. Brno: Masarykův onkologický ústav.; 2021.
    20. Wong RK, Tandan V, De Silva S, Figueredo A. Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma. Cochrane Database Syst Rev. 2007(2):Cd002102. Go to original source...
    21. Zhao F, Wang J, Yu H, Cheng X, Li X, Zhu X, et al. Neoadjuvant radiotherapy improves overall survival for T3/4N+M0 rectal cancer patients: a population-based study of 20300 patients. Radiat Oncol. 2020;15(1):49. Go to original source... Go to PubMed...
    22. Pahlman L, Bohe M, Cedermark B, Dahlberg M, Lindmark G, Sjodahl R, et al. The Swedish rectal cancer registry. Br J Surg. 2007;94(10):1285-1292. Go to original source... Go to PubMed...
    23. Song JH, Jeong JU, Lee JH, Kim SH, Cho HM, Um JW, et al. Preoperative chemoradiotherapy versus postoperative chemoradiotherapy for stage II-III resectable rectal cancer: a meta-analysis of randomized controlled trials. Radiat Oncol J. 2017;35(3):198-207. Go to original source... Go to PubMed...
    24. McCarthy K, Pearson K, Fulton R, Hewitt J. Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer. Cochrane Database Syst Rev. 2012;12:Cd008368. Go to original source... Go to PubMed...
    25. Pollack J, Holm T, Cedermark B, Holmstrom B, Mellgren A. Long-term effect of preoperative radiation therapy on anorectal function. Dis Colon Rectum. 2006;49(3):345-352. Go to original source... Go to PubMed...
    26. Peeters KC, van de Velde CJ, Leer JW, Martijn H, Junggeburt JM, Kranenbarg EK, et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study. J Clin Oncol. 2005;23(25):6199-6206. Go to original source... Go to PubMed...
    27. Benson A, Venook A, Al-Hawary M. Rectal Cancer. NCCN Clinical Practice Guidelines in Oncology. 2019 www.nccn.org.
    28. You YN, Hardiman KM, Bafford A, Poylin V, Francone TD, Davis K, et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Rectal Cancer. Dis Colon Rectum. 2020;63(9):1191-222. Go to original source... Go to PubMed...
    29. Clancy C, Burke JP, Albert MR, O'Connell PR, Winter DC. Transanal endoscopic microsurgery versus standard transanal excision for the removal of rectal neoplasms: a systematic review and meta-analysis. Dis Colon Rectum. 2015;58(2):254-261. Go to original source... Go to PubMed...
    30. Lee L, Edwards K, Hunter IA, Hartley JE, Atallah SB, Albert MR, et al. Quality of Local Excision for Rectal Neoplasms Using Transanal Endoscopic Microsurgery Versus Transanal Minimally Invasive Surgery: A Multi-institutional Matched Analysis. Dis Colon Rectum. 2017;60(9):928-935. Go to original source... Go to PubMed...
    31. Kidane B, Chadi SA, Kanters S, Colquhoun PH, Ott MC. Local resection compared with radical resection in the treat­ment of T1N0M0 rectal adenocarcinoma: a systematic review and meta-analysis. Dis Colon Rectum. 2015;58(1):122-140. Go to original source... Go to PubMed...
    32. Halverson AL, Morris AM, Cleary RK, Chang GJ. For Patients with Early Rectal Cancer, Does Local Excision Have an Impact on Recurrence, Survival, and Quality of Life Relative to Radical Resection? Ann Surg Oncol. 2019;26(8):2497-2506. Go to original source... Go to PubMed...
    33. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery--the clue to pelvic recurrence? Br J Surg. 1982;69(10):613-616. Go to original source... Go to PubMed...
    34. Quirke P, Dixon MF, Durdey P, Williams NS. LOCAL RECURRENCE OF RECTAL ADENOCARCINOMA DUE TO INADEQUATE SURGICAL RESECTION: Histopathological Study of Lateral Tumour Spread and Surgical Excision. The Lancet. 1986;328(8514):996-999. Go to original source... Go to PubMed...
    35. Grega M, Vjaclovský M, Chmelová R, Pazdírek F, Kodet R, Hoch J. Lymph nodes detection and the mesorectal excision quality evaluation. Rozhl Chir. 2019;98(5):200-206. Go to original source... Go to PubMed...
    36. Quirke P, Steele R, Monson J, Grieve R, Khanna S, Couture J, et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet. 2009;373(9666):821-828. Go to original source... Go to PubMed...
    37. Yu HC, Peng H, He XS, Zhao RS. Comparison of short- and long-term outcomes after extralevator abdominoperineal excision and standard abdominoperineal excision for rectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis. 2014;29(2):183-191. Go to original source... Go to PubMed...
    38. Rao X, Zhang J, Liu T, Wu Y, Jiang Y, Wang P, et al. Prognostic value of inferior mesenteric artery lymph node metastasis in cancer of the descending colon, sigmoid colon and rectum. Colorectal Dis. 2018;20(6):o135-o42. Go to original source... Go to PubMed...
    39. Georgiou P, Tan E, Gouvas N, Antoniou A, Brown G, Nicholls RJ, et al. Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol. 2009;10(11):1053-1062. Go to original source... Go to PubMed...
    40. Collaborative. TBT. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg. 2013;100(8):1009-1014. Go to original source... Go to PubMed...
    41. Hoch J, Ferko A, Bláha M, Ryška A, Čapov I, Dušek L, et al. Parametric monitoring of the quality of total mesorectal excision and surgical treatment of rectal carcinoma results of a multicenter study. Rozhl Chir. 2016;95(7):262-271. Go to PubMed...
    42. Pisarska M, Gajewska N, Małczak P, Wysocki M, Witowski J, Torbicz G, et al. Defunctioning ileostomy reduces leakage rate in rectal cancer surgery - systematic review and meta-analysis. Oncotarget. 2018;9(29):20816-20825. Go to original source... Go to PubMed...
    43. Wu S-W, Ma C-C, Yang Y. Role of protective stoma in low anterior resection for rectal cancer: a meta-analysis. World journal of gastroenterology. 2014;20(47):18031-18037. Go to original source... Go to PubMed...
    44. Pommergaard HC, Gessler B, Burcharth J, Angenete E, Haglind E, Rosenberg J. Preoperative risk factors for anastomotic leakage after resection for colorectal cancer: a systematic review and meta-analysis. Colorectal Dis. 2014;16(9):662-671. Go to original source... Go to PubMed...
    45. Wang CL, Qu G, Xu HW. The short- and long-term outcomes of laparoscopic versus open surgery for colorectal cancer: a meta-analysis. Int J Colorectal Dis. 2014;29(3):309-320. Go to original source... Go to PubMed...
    46. Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, Copeland J, et al. Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer: The ROLARR Randomized Clinical Trial. Jama. 2017;318(16): 1569-1580. Go to original source... Go to PubMed...
    47. Broholm M, Pommergaard HC, Gögenür I. Possible benefits of robot-assisted rectal cancer surgery regarding urological and sexual dysfunction: a systematic review and meta-analysis. Colorectal Disease. 2015;17(5):375-381. Go to original source... Go to PubMed...
    48. Lei P, Ruan Y, Yang X, Fang J, Chen T. Trans-anal or trans-abdominal total mesorectal excision? A systematic review and meta-analysis of recent comparative studies on perioperative outcomes and pathological result. Int J Surg. 2018;60:113-119. Go to original source... Go to PubMed...
    49. Larsen SG, Pfeffer F, Kørner H. Norwegian moratorium on transanal total mesorectal excision. Br J Surg. 2019;106(9): 1120-1121. Go to original source... Go to PubMed...
    50. An international multicentre prospective audit of elective rectal cancer surgery; operative approach versus outcome, including transanal total mesorectal excision (TaTME). Colorectal Dis. 2018;20 Suppl 6:33-46. Go to PubMed...
    51. Pazdirek F, Minarik M, Benesova L, Hoch J, Lohynska R. Current possibilities of predicting the therapeutic response to neoadjuvant chemoradiotherapy in rectal cancer.: Gas­troent Hepatol; 2020. p. 393-403. Go to original source...
    52. Maas M, Beets-Tan RG, Lambregts DM, Lammering G, Nele­mans PJ, Engelen SM, et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol. 2011;29(35):4633-4640. Go to original source... Go to PubMed...
    53. Araghi M, Arnold M, Rutherford MJ, Guren MG, Cabasag CJ, Bardot A, et al. Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project). Gut. 2021;70(1):114. Go to original source... Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.